Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

1.3K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.3K
Pneumothorax-I01:26

Pneumothorax-I

1.9K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

992
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
992
Flail Chest-II01:26

Flail Chest-II

820
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
820

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival outcomes for post-endoscopy upper gastrointestinal cancer in England.

Endoscopy·2026
Same author

The association between individual and neighbourhood-level measures of socioeconomic disadvantage and severe maternal morbidity, in the Netherlands, a retrospective cohort study.

European journal of public health·2026
Same author

Irinotecan with trifluridine/tipiracil and bevacizumab for second-line metastatic colorectal cancer: a phase II multicenter study.

Signal transduction and targeted therapy·2026
Same author

Differences in Endoscopy Characteristics Between Providers With the Highest and Lowest Post Endoscopy Upper Gastrointestinal Cancer Rates in England.

United European gastroenterology journal·2026
Same author

Colorectal cancer outcomes show relationships with the type and extent of vascular complications in individuals with diabetes: A population-based study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

CoagLite: A low-computational-cost integral model for simulating indoor ultrafine particle dynamics.

Journal of hazardous materials·2026

Related Experiment Video

Updated: Mar 13, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

14.9K

Trends in pneumothorax mortality in England (2004-2023): a population-based observational study.

Xiaomin Zhong1, Eva J A Morris1, Raph Goldacre1

  • 1Applied Health Research Unit, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

The Lancet Regional Health. Europe
|March 12, 2026
PubMed
Summary

Spontaneous pneumothorax mortality in England declined until 2019, then rose, with COVID-19 impacting 2021 rates. Underestimating pneumothorax

Keywords:
COVIDEpidemiologyMortalityPneumothorax

More Related Videos

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

2.5K
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

6.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

14.9K
Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

2.5K
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

6.8K

Area of Science:

  • Public Health
  • Respiratory Medicine
  • Epidemiology

Background:

  • Monitoring pneumothorax mortality is crucial for understanding disease burden and guiding healthcare planning.
  • This study focuses on spontaneous pneumothorax (SP) mortality trends in England from 2004 to 2023.

Purpose of the Study:

  • To analyze spontaneous pneumothorax mortality trends in England over a 20-year period.
  • To identify changes in mortality rates and contributing factors, including the impact of COVID-19.

Main Methods:

  • Population-based observational study using linked national death registrations and Hospital Episode Statistics.
  • SP-related mortality defined by any mention on death certificates; SP-specific by underlying cause.
  • Modified definitions for primary and secondary SP included patients with or without chronic lung disease.

Main Results:

  • A total of 6,442 SP-related deaths were identified; 5,055 were in-hospital deaths.
  • SP-related mortality rates declined from 2004-2019 but increased post-2019, peaking in 2021.
  • The 2021 mortality surge was largely COVID-related; non-COVID mortality remained stable.

Conclusions:

  • The COVID-19 pandemic disrupted the declining trend of SP mortality.
  • Relying solely on underlying cause of death underestimates pneumothorax's contribution to mortality.
  • Pneumothorax is a significant cause of mortality, especially in those over 65, with or without lung disease.